LUNGevity Foundation Announces New Research Awards for 2025
Exciting opportunities for lung cancer research funding are now available.
LUNGevity Foundation, a prominent organization dedicated to advancing lung cancer research, is thrilled to announce four Requests for Applications (RFAs) aimed at fostering growth within the lung cancer research community.
Dr. Upal Basu Roy, the executive director of LUNGevity Research, emphasized that the vitality of the research community is crucial for enhancing early detection and treatment of lung cancer. "Our awards are designed to meet the specific needs of those involved in lung cancer research, facilitating the development of a robust workforce dedicated to improving the lives of patients," he stated.
Focus Areas of the Research Awards
In 2025, LUNGevity will offer the following main awards designed to boost workforce development:
Career Development Awards (CDAs)
Celebrating their 13th year, the CDAs represent LUNGevity's flagship initiative. These awards are well-known for providing both financial aid and valuable networking opportunities for early-career researchers aiming to elevate their expertise.
Dr. Amy Moore, vice president of Global Engagement and Research Partnerships, commented on the urgency of supporting lung cancer research. "Despite being the leading cause of cancer deaths, lung cancer research receives a meager 6% of federal cancer research funding. LUNGevity's CDAs serve as a vital resource for upcoming researchers seeking to establish themselves in this critical field," she remarked.
The maximum funding offered through CDAs is $300,000 over three years.
Health Equity and Inclusiveness Research Fellow Awards
Introduced in 2021, this award underscores LUNGevity's commitment to equity and inclusivity in lung cancer research. With this initiative, LUNGevity aims to empower a diverse research workforce that reflects the needs of marginalized communities.
Recipients of this award can receive up to $100,000 over two years.
Veterans Affairs Research Scholar Awards
Recognizing that veterans face elevated risks for lung cancer, LUNGevity continues its support for veterans and associated healthcare initiatives. This award targets researchers committed to exploring lung cancer issues within the U.S. Department of Veterans Affairs.
Eligible scholars may receive awards of $100,000 over a two-year period.
ASTRO-LUNGevity Residents/Fellows in Radiation Oncology Seed Grants
For the fourth consecutive year, LUNGevity collaborates with the American Society for Radiation Oncology to nurture the research endeavors of residents and fellows interested in radiation oncology related to lung cancer.
This grant provides up to $50,000 for a one-year project.
Application Process for Research Awards
The deadline for submitting applications for the ASTRO-LUNGevity Residents/Fellows in Radiation Oncology Seed Grants is March 10, 2025. For all other awards, interested candidates must first submit a letter of intent by February 14, 2025. Detailed information about the application processes can be found on the LUNGevity website.
The recipients for these prestigious awards are expected to be announced in late summer 2025.
About LUNGevity Foundation
LUNGevity Foundation is at the forefront of transforming the landscape of lung cancer diagnosis and treatment. The organization is dedicated to making significant strides in improving survivorship and quality of life for all affected by the disease.
Through comprehensive research initiatives, advocacy efforts, and community support, LUNGevity aims to address disparities and foster advancements in lung cancer care.
- Innovative Research: LUNGevity employs a holistic approach to facilitate earlier lung cancer detection and to continue developing better treatment options.
- Advocacy Efforts: The foundation actively engages in collaborations to enhance patient access to diagnostic testing and treatment options.
- Community Support: LUNGevity connects individuals affected by lung cancer with essential resources, enabling them to access the best healthcare possible.
The organization provides an array of resources including a user-friendly website, specialized support channels, patient conferences, and navigational tools for clinical trials—all geared toward creating an environment where no one loses their life to lung cancer. LUNGevity is a proud recipient of a four-star rating from Charity Navigator.
About Lung Cancer in the United States
- Approximately 1 in 18 Americans are projected to be diagnosed with lung cancer in their lifetime.
- Over 234,000 new lung cancer diagnoses are expected to occur this year, translating to about one diagnosis every 2.2 minutes.
- Nearly 65% of new lung cancer cases involve individuals with no significant history of tobacco use.
- Lung cancer surpasses colorectal and pancreatic cancers combined in terms of mortality rates.
- Despite grim statistics, early detection can significantly improve five-year survival rates, raising the odds to 64%.
Frequently Asked Questions
What is the purpose of LUNGevity's 2025 RFAs?
The RFAs are aimed at fostering workforce development and enhancing research in lung cancer, focusing on inclusivity and diverse initiatives.
How are the Career Development Awards beneficial to researchers?
The Career Development Awards provide essential funding and networking opportunities for early-career researchers, essential for establishing themselves in the field.
What types of awards is LUNGevity offering for 2025?
LUNGevity is offering Career Development Awards, Health Equity and Inclusiveness Research Fellow Awards, Veterans Affairs Research Scholar Awards, and ASTRO-LUNGevity Seed Grants.
How can interested applicants access more information?
Applicants can find detailed application requirements and processes on the LUNGevity website.
When can we expect to hear about award recipients?
Award recipients will be announced in late summer 2025.
